Nanotrace
Nanotrace makes cancer programmable. AI-designed nanoparticles read each cell’s genetic signature and release therapy only inside tumors — unlocking the cancers chemo and antibodies can’t touch.
Details
-
Industries
Biotech Medtech HealthTech
-
Operating Status
Open
Currently Raising - Website
Founders
-
Will Briley
Founder
-
Paul Weiss
Founder
-
Dave Spector
Founder